📰 Statement Regarding News
Page 43 - Statement Regarding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.
February 8, 2023
Federal Trade Commission FTC has proposed rule that would ban essentially all non-compete agreements. Rule would purport to override tens of millions of contracts in every sector. Treasury Department issued Non-Compete Contracts: Economic Effects and Policy Implications.
February 8, 2023
The Federal Trade Commission (FTC) has proposed a paradigm-breaking rule that would ban essentially all non-compete agreements. If enacted, this rule would purport to override tens of...
February 6, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS 06.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CSE: DTC       FSE: DTC  &nbsp...
February 6, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS 06.02.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. CSE: DTC FSE: DTC U...
February 3, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE THERAPEUTICS AND CQDM FUND THE DEVELOPMENT OF A NEW CANCER VACCINE PLATFORM 03.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.___________________________________________CSE: DTC   FSE: DTC...
February 3, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE THERAPEUTICS AND CQDM FUND THE DEVELOPMENT OF A NEW CANCER VACCINE PLATFORM 03.02.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. ___________________________________________ CSE:...
February 3, 2023
PressNetwork – Presseportal für Pressemitteilungen und Unternehmens-News
February 3, 2023
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company
February 2, 2023
Montreal, Quebec--(Newsfile Corp. - February 2, 2023) - In celebration of World Cancer Day, Defence Therapeutics and CQDM are proud to announce the launch of a collaborative research project between Université
February 1, 2023
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.